Programme | Belarusian Pharmaceutical Forum

Print version

Day 1 – Wednesday, 27 May

08.00 – 09.00	Registration and morning coffee
09.00 – 09.10	Opening of the 1^st Belarusian Pharmaceutical Forum. Welcome Address by Natalia Baeva, Director of the Global Pharmaceutical Leaders' Club
09.10 – 09.20	Welcome Address by Deputy Prime Minister of the Republic of Belarus Natalia Petkevich (invited)
09.20 – 09.30	Welcome Address by Aliaksandr Khajayeu, Minister of Healthcare of the Republic of Belarus / Elena Bogdan, 1^st Deputy Minister, Ministry of Healthcare of the Republic of Belarus
09.30 – 09.40	Welcome Address by Arthur Karpovich, Minister of Antimonopoly Regulation and Trade of the Republic of Belarus
09.40 – 10.00	Keynote presentation "Pharmaceutical Landscape of the EAEU: Opportunities for Belarus and Industry Expansion"
10.00 – 11.00	Session 1. Developing the Common Pharmaceutical Market of the EAEU: Integration, Harmonisation and Future Prospects How is the development of the common pharmaceutical market of the EAEU progressing, and what results have been achieved to date? Harmonisation of requirements for the registration of medicinal products and medical devices: progress made and outstanding challenges. Transition to Union-wide registration procedures: practical implications for national and international companies. Mutual recognition of expert evaluations, GMP inspections and pharmacovigilance activities within the EAEU framework. Pricing and public procurement in the context of integration: is alignment of approaches feasible? Digitalisation of regulatory processes and the creation of a unified information space within the EAEU. Speakers: Elena Bogdan, 1^st Deputy Minister, Ministry of Healthcare of the Republic of Belarus Dmitry Grinko, Director, Center for Examinations and Tests in Health Service of the Ministry of Healthcare of Belarus Dmitry Rozhdestvensky, Head of the Department for Coordination of Activities in the Circulation of Medicinal Products and Medical Devices, Department of Technical Regulation and Accreditation, Eurasian Economic Commission Alla Trapkova, Deputy General Director, Scientific Centre for Expert Evaluation of Medicinal Products (Russia) Gabit Seidualiyev, Deputy General Director for Strategic Development – Member of the Board, National Centre for Pharmaceutical Drugs and Medical Devices Expertise (Kazakhstan)
11.00 – 11.15	Special presentation: "Market Entry Strategy: Approaches to Selecting a Reference Country" Speaker: Alexander Matyushenok, QA manager, PharmAssistance
11.15 – 11.40	Coffee and Networking Break
11.40 – 12.40	Session 2. From Localisation to Export - Strategic Priorities of Belarusian Pharmaceutical Industry What key directions and trends currently shape the development of local pharmaceutical manufacturing in Belarus? Which government support measures and regulatory initiatives contribute to the expansion of localized production? What opportunities do free economic zones and tax incentives offer to pharmaceutical companies? Which factors influence the export potential of Belarusian pharmaceutical products, and what barriers do they face when entering international markets? How do technological advancements and access to modern manufacturing solutions affect the competitiveness of Belarusian pharma? Moderator: Anton Kugach, General Director, R-Pharm Integration Speakers: Igor Mitrofanov, General Director, Managing Company of Belpharmprom Ivan Logovoy, Chairman of the Board of Directors, Pharmland Belmedpreparaty BORIMED
12.40 – 13.40	Lunch
13.40 – 14.40	Session 3. Medicines Pricing Regulation - Balancing Affordability, Quality, and Market Sustainability What pricing mechanisms operate in the Belarusian pharmaceutical market, and how do they ensure the accessibility of medicines for the population? How does price regulation affect market sustainability and the competitiveness of domestic and international manufacturers? What approaches are used to maintain a balance between medicine affordability and support for innovation? Which prospective initiatives or changes in price regulation are being considered to improve market transparency and predictability? Moderator: Natalia Makeeva, Executive Director, Association of the International Pharmaceutical Producers of the Republic of Belarus Speakers: Natalia Vasilevskaya, First Deputy Minister, Ministry of Antimonopoly Regulation and Trade of the Republic of Belarus Anatoly Yurastov, Head of the Social Sector and Services Department, Ministry of Antimonopoly Regulation and Trade of the Republic of Belarus Representative, Ministry of Health of the Republic of Belarus Representative, Center for Examinations and Tests in Health Service of the Ministry of Healthcare of Belarus Gabit Seidualiyev, Deputy General Director for Strategic Development – Member of the Board, National Centre for Pharmaceutical Drugs and Medical Devices Expertise (Kazakhstan)
14.40 – 15.00	Special Presentation: "Tools for Expanding Patient Access to Innovative Therapies" Speaker: Alexander Ivanov, Head of Strategic Consulting Department, Aston Health
15.00 – 16.00	Session 4. Global Strategies and Local Trends in Belarus' Pharmaceutical Market - Insights from Top Pharma Executives Which local trends in the Belarusian pharmaceutical market have the greatest impact on strategic decisions by international companies? What challenges do international companies face when operating in the public and commercial sectors? How do companies adapt their innovation strategies and product portfolios to the specific characteristics of the Belarusian market? What opportunities for collaboration and investment do market players see within Belarus and across the EAEU? How is the distribution and pharmacy segment developing, and what strategies are companies using to ensure effective market coverage? Moderator: Natalia Makeeva, Executive Director, Association of the International Pharmaceutical Producers of the Republic of Belarus Speakers: Tatiana Kubasova, Business Development & Frontier Markets Director, Russia and Eurasia, AstraZeneca Aleh Nauras, Country Manager, Takeda Belarus Denis Chetverikov, President, Akrikhin Блок дистрибьюторов и аптечных сетей Leonid Tomchin, Chairman of the Board of Directors, Management Company of Apteka Group Holding Sergey Shakutin, Owner and General Director, Iskamed Ivan Kozyrev, Director, Unipharm Sergey Shugaev, Deputy Director, MedWay / Flora Pharm
16.00 – 16.10	Spotlight Presentation "Leveraging Digital Solutions in Pharma: How to Transform Operations and Marketing Effectively" DORI DIGITAL
16.10 – 16.30	Coffee and Networking Break
16.30 – 17.30	Session 5. Public Procurement - Transparency, Efficiency, and Industry Development What modern mechanisms ensure transparency and efficiency in public procurement of medicines in Belarus? How does current public procurement practice affect medicine accessibility for the population and the development of domestic manufacturers? What tools are used to stimulate competition and support innovative and locally produced medicines within public procurement? What changes are being considered to improve the predictability and sustainability of the public procurement system? Moderator: Vaceslav Zenkovich, Director, Smartpress.by Speakers: Representative, Ministry of Health of the Republic of Belarus Sergey Novikov, Head of Procurement Regulation Department, Ministry of Antimonopoly Regulation and Trade of the Republic of Belarus Representative, Belpharmacy Alexey Menkov, Head of Market Access and External Affairs, Belarus, AstraZeneca
17.30 – 18.30	Session 6. Dietary Supplements as a Driver of Health and Business - What Is Needed to Develop the Segment? Which market trends and consumer drivers are shaping the growth of the dietary supplements segment? What registration barriers most often delay the introduction of new dietary supplements to the market? To what extent do current regulatory requirements keep pace with innovation in the dietary supplements segment? How can harmonization of requirements with the EAEU support segment growth and entry into new markets? Which best practices from the EAEU could be applied to develop the national dietary supplements market? How can consumer trust and engagement be enhanced through marketing, education, and transparency? Speakers: Representative, Ministry of Health of the Republic of Belarus Representative, Republican Centre for Hygiene, Epidemiology and Public Health Representative, Research Institute of Hygiene, Toxicology, Epidemiology, Virology and Microbiology
18.30 – 19.30	B2G meetings with representatives of regulatory authorities / B2B one-on-one meetings with top executives from pharmaceutical and medical device manufacturers, distributors, and pharmacy chains Belpharmacy VitPharmMarket Iskamed Pharmico Unipharm Brititrade Medvax Medway Bimed Pharm (Kyrgyzstan) Myratly Gadam (Turkmenistan)
19.30 – 21.00	Cocktail Reception

Day 2 – Thursday, 28 May

08.30 – 09.30

Registration and morning coffee

09.30 – 10.30 Session 7. Registration and Re-registration of Medicines and Medical Devices – Barriers, Solutions, and Growth Opportunities

Union vs. national registration: how to make the optimal regulatory decision?
From dossier submission to approval: where do the “bottlenecks” occur and how can they be resolved?
Regulatory pathway for medical devices: from risk classification to authorization.
Regulatory barriers for local and international manufacturers of medicines and medical devices: GMP, pharmacovigilance, and post-registration obligations.

Olga Zhuravleva, Deputy Director, Center for Examinations and Tests in Health Service of the Ministry of Healthcare of Belarus
Alla Trapkova, Deputy General Director, Scientific Centre for Expert Evaluation of Medicinal Products (Russia)
Representative, State Pharmaceutical Inspectorate for Medicines Circulation ("Gospharmnadzor")
Irene Voitehsko, Head of Regulatory Affairs, Frontier Markets, AstraZeneca
Hanna Volkava, Head of Regulatory Affairs Department, PharmAssistance

10.30 – 11.00 Coffee and Networking Break

11.00 – 12.00 Round table "Registration and Re-registration of Medicines: National and EAEU Standards on the Path to Safety and Quality"

Olga Zhuravleva, Deputy Director, Center for Examinations and Tests in Health Service of the Ministry of Healthcare of Belarus
Alla Trapkova, Deputy General Director, Scientific Centre for Expert Evaluation of Medicinal Products (Russia)
Representative, State Pharmaceutical Inspectorate for Medicines Circulation ("Gospharmnadzor")

12.00 – 13.00 Round table "Clinical Trials in Belarus and the EAEU: Standards, Practice, and Prospects"

Representative, Center for Examinations and Tests in Health Service of the Ministry of Healthcare of Belarus
Yuri Khvedchin, Business Development Manager, PharmAssistance

09.30 – 13.00 Expert Roundtable Sessions – discussions in an intimate setting, providing the opportunity to ask questions and exchange views in a more relaxed atmosphere

Round table 1. Rules for Dietary Supplements: Regulation, Control, and Market Development

Representative, Republican Centre for Hygiene, Epidemiology and Public Health
Representative, Research Institute of Hygiene, Toxicology, Epidemiology, Virology and Microbiology

Round table 2. Protecting Innovation: A Strategic Approach to Intellectual Property in Pharma

Representative, Ministry of Health of the Republic of Belarus
Alena Usachova, First Deputy General Director, National Center of Intellectual Property
Galina Vashuk, Patent and Trademark Attorney of the Republic of Belarus, Lexpatent
Darya Lando, Head of the Legal Department, Lexpatent

Round table 3. Restricted Lists of Medicines: Approaches, Challenges, and Planned Changes

Representative, Ministry of Health of the Republic of Belarus
Representative, Republican Scientific and Practical Centre for Medical Technologies

Round table 4. Access to Therapy for Rare Diseases: Strategy and Practice

Representative, Ministry of Health of the Republic of Belarus
Representative, Republican Scientific and Practical Centre "Mother and Child"
Alexander Ivanov, Head of Strategic Consulting Department, Aston Health

13.00 – 13.30	Transfer to lunch
13.30 – 14.30	Lunch
14.30 – 17.30	Visits to a Pharmaceutical Manufacturing Plant / Distributor Warehouse
17.30	Closing of the 1^st Belarusian Pharmaceutical Forum

Print version

Day 1 – Wednesday, 27 May

Day 2 – Thursday, 28 May

Join our Telegram channel